MEDIUM confidence: 100% data completeness, but the composite (52) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Avg target $364 (last qtr, 5 analysts) → $384 (last mo, 3) (+5.5%).
Buy-rated share 46% → 50% over ~3 months (+4pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $4.36 | $5.48 | +25.7% |
| Jul 2026 | $3.79 | $5.27 | +39.1% |
| May 2026 | $3.70 | $3.79 | +2.4% |
| Feb 2026 | $3.72 | $4.04 | +8.6% |
| Oct 2025 | $3.30 | $3.68 | +11.5% |
| Jul 2025 | $3.23 | $3.86 | +19.5% |
| May 2025 | $2.90 | $3.79 | +30.7% |
| Feb 2025 | $3.28 | $3.15 | -4.0% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 5.1%/yr (revenue basis).
Base free cash flow $499M (avg FY2023–FY2025; latest year $794M) · equity value $12.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$5.6M over 180 days (0 open-market buys, 3 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $9.5B— | $10.7B+12.1% | $11.5B+7.3% | $11.5B+0.7% | $12.5B+8.2% |
| EPS (dil.) | $13.50— | $14.44+7.0% | $17.07+18.2% | $13.96-18.2% | $15.39+10.2% |
| Free Cash Flow | $429M— | $482M+12.4% | $678M+40.7% | $26M-96.2% | $794M+2953.8% |
| Gross Margin | 14.4% | 13.5%-0.9pp | 14.4%+0.9pp | 12.6%-1.8pp | 12.7%+0.1pp |
| Operating Margin | 5.4% | 5.3%-0.1pp | 6.8%+1.5pp | 4.6%-2.2pp | 4.9%+0.2pp |
| Net Margin | 5.7% | 5.4%-0.3pp | 5.9%+0.5pp | 4.8%-1.2pp | 4.8%+0.1pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
The QScore of 52 for Huntington Ingalls Industries indicates a neutral outlook, with the stock scoring high on value and growth, driven by a reasonable P/E of 17.1 and strong EPS growth of 10.2%. However, it exhibits weaker profitability, with an ROE of 13.9% and operating margin of 5.7%, which weighs on its overall score. The stock's momentum is also mixed, with a 6.2% return over the past year, but a recent decline of 2.8% over the past three months, resulting in a short-term score that is largely in line with its long-term score.